Patent granted for Multiple Sclerosis drug Tecfidera (BG-12) until 2028
Biogen Idec Inc announces it has been granted a new patent that will help protect the market exclusivity of its multiple sclerosis drug Tecfidera (BG-12) until 2028.
The new patent covers the dosing regimen for Tecfidera of 480 milligrams a day....Read more - http://www.ms-uk.org/index.cfm/BG12
Patent granted for MS drug Tecfidera (BG-12) until 2028
Patent granted for MS drug Tecfidera (BG-12) until 2028
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 8 Replies
- 7621 Views
-
Last post by Algis
-
- 0 Replies
- 6731 Views
-
Last post by NHE
-
- 0 Replies
- 645 Views
-
Last post by NHE
-
- 0 Replies
- 1720 Views
-
Last post by NHE
-
- 1 Replies
- 3342 Views
-
Last post by Tif
-
- 0 Replies
- 289 Views
-
Last post by DIM
-
- 2 Replies
- 1214 Views
-
Last post by DIM
-
- 1 Replies
- 2123 Views
-
Last post by raceya